MedTrace Logo

Aortic Valve replAcement in eLective Patients From aOrtic Valve multiceNter Registry

NCT05308173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2393

Last updated 2022-04-01

No results posted yet for this study

Summary

Multicenter registry data analysis of aortic valve stenosis patients that underwent elective, isolated transcutaneous aortic valve implantation (TAVI) or surgical aortic valve replacement between 2015 and 2019. In TAVI group only transfemoral access was considered.

Conditions

  • Aortic Valve Stenosis

Interventions

PROCEDURE

Surgical Aortic Valve Replacement

Cardiac surgery under cardio-pulmonary bypass, via sternotomy or minimally invasive approach with the replacement of native valve with a biological or mechanic prosthesis.

PROCEDURE

Transcutenous Aortic Valve Implantation

Transfemoral implantation of aortic bioprosthesis with one of the devices available in Poland.

Sponsors & Collaborators

  • Nicolaus Copernicus University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2021-06-30
Completion
2021-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308173 on ClinicalTrials.gov